Inventor
RHONEMUS TROY
US10 patents
Patents
10 patentsUS10000520B2Jun 19, 2018
B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof
CHROMADEX INC6 citations80
US10280190B2May 7, 2019
Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditions
CHROMADEX INC6 citations71
US10934322B2Mar 2, 2021
B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof
CHROMADEX INC4 citations69
US10183036B2Jan 22, 2019
Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors
CHROMADEX INC6 citations68
US12433908B2Oct 7, 2025
Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development
CHROMADEX INC0 citations57
US11524022B2Dec 13, 2022
Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development
CHROMADEX INC0 citations57
US11214589B2Jan 4, 2022
Crystalline forms of nicotinoyl ribosides and derivatives thereof, and methods of preparation thereof
CHROMADEX INC0 citations56
US11033568B2Jun 15, 2021
Nicotinamide riboside compositions for topical use in treating skin conditions
CHROMADEX INC0 citations53
US10857172B2Dec 8, 2020
Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development
CHROMADEX INC0 citations46
US10688118B2Jun 23, 2020
Nicotinamide riboside compositions for topical use in treating skin conditions
CHROMADEX INC0 citations42